ANDERSON HOAGLAND & CO – Regeneron Pharmaceuticals, Inc. Transaction History
ANDERSON HOAGLAND & CO portfolio value:
$3.11M
portfolio value
ANDERSON HOAGLAND & CO quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.36% | 16 shares | 378K | $688.87 | 4.52K |
| Q2 2022 | share | 0.00% | 0 shares | -410K | $591.13 | 4.50K | |
| Q1 2022 | share | 0.00% | 0 shares | 347K | $698.42 | 4.50K | |
| Q4 2021 | share | Increase | +2.02% | 89 shares | 127K | $642.51 | 4.50K |
| Q3 2021 | share | Increase | 0.00% | 4.41K shares | 2.67M | $605.18 | 4.41K |
| Q1 2021 | share | Decrease | -100.00% | -2.62K shares | -1.26M | $473.14 | 0 |
| Q4 2020 | share | Increase | +69.29% | 1.07K shares | 301K | $483.11 | 2.62K |
| Q3 2020 | share | Decrease | -3.13% | -50 shares | -31K | $559.78 | 1.55K |
| Q2 2020 | share | Increase | 0.00% | 1.6K shares | 998K | $623.65 | 1.6K |
| Q1 2017 | share | Decrease | -100.00% | -1.4K shares | -514K | $387.51 | 0 |
| Q4 2016 | share | 0.00% | 0 shares | -49K | $367.09 | 1.4K | |
| Q3 2016 | share | 0.00% | 0 shares | 74K | $402.02 | 1.4K | |
| Q2 2016 | share | 0.00% | 0 shares | -16K | $349.23 | 1.4K | |
| Q1 2016 | share | Increase | 0.00% | 1.4K shares | 505K | $360.44 | 1.4K |